甲磺酸伊马替尼的合成工艺改进
投稿时间:2013-03-12  修订日期:2013-12-05  点此下载全文
引用本文:徐晓霞,闵涛,史为龙.甲磺酸伊马替尼的合成工艺改进[J].药学实践杂志,2014,32(4):290~293
摘要点击次数: 1220
全文下载次数: 298
作者单位
徐晓霞 南京优科生物医药有限公司, 江苏 南京 210018 
闵涛 南京优科生物医药有限公司, 江苏 南京 210018 
史为龙 南京优科生物医药有限公司, 江苏 南京 210018 
中文摘要:目的 改进甲磺酸伊马替尼的合成工艺。方法 以4-[(4-甲基哌嗪-1-基)甲基]苯甲酰氯二盐酸盐与4-甲基-N3-[4-(3-吡啶基)嘧啶-2-基]-1,3苯二胺为起始原料,进行水相缩合反应得到伊马替尼游离碱,再与甲磺酸成盐,两步反应合成新型酪氨酸酶抑制剂类抗肿瘤药物伊马替尼。结果 优化后的工艺成本低廉、后处理简便、产品纯度高、收率高,并且对环境污染小。纯度可达99.7%,且单一杂质<0.1%。结论 新工艺的总收率达81.5%,可工业化生产,前景广阔。目标产物结构经1H NMR,ESI-MS得到结构确证。
中文关键词:甲磺酸伊马替尼  水相合成  工艺改进
 
Improved synthesis of imatinib mesylate
Abstract:Objective To obtain the improved synthesis of imatinib mesylate.Methods 4-[(4-methyl-piperazin-1-yl) methyl] benzoyl chloride dihydrochloride and 4-methyl-N3-[4-(3-pyridyl) pyrimidin-2-yl]-1,3-phenylenediamine were used as starting raw material to perform a condensation reaction in the aqueous phase to give imatinib free base, which was then neutralized with methanesulfonic acid to obtain the novel antineoplastic tyrosinase inhibitor imatinib mesylate by the use of a two-step reaction.Results The improved synthesis was considered to have the advantages of low cost, easy post-processing, high purity, high yield and environmental pollution with the HPLC purity≥99.7% and the single impurity<0.1%.Conclusion The total yield of the novel method was 81.5%, having an enough broad industrial production prospect.The targeted compound structure was confirmed by 1H NMR and ESI-MS.
keywords:imatinib mesylate  aqueous phase synthesis  improved synthesis
查看全文  查看/发表评论  下载PDF阅读器
关闭

分享按钮